MONOLITHIC POWER SYSTEMS INC
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of Monolithic Power Systems, Inc., a Delaware corporation, and its wholly owned subsidiaries (the “Company” or “MPS”) have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted in accordance with these accounting principles, rules and regulations. All intercompany accounts and transactions have been eliminated. The information in this report should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 3, 2025.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods presented. The financial statements contained in this Quarterly Report on Form 10-Q are not necessarily indicative of the results that may be expected for the year ending December 31, 2025 or for any other future periods.
Summary of Significant Accounting Policies
There have been no changes to the Company’s significant accounting policies during the three and nine months ended September 30, 2025 from those described in the Company’s audited consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2024.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions used in these condensed consolidated financial statements primarily include those related to income tax valuation allowances, inventory valuation and stock-based compensation. Actual results could differ from these estimates and assumptions, and any such differences may be material to the Company’s condensed consolidated financial statements.
New Accounting Pronouncements Not Yet Adopted as of September 30, 2025
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09,* Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, which aims to improve an entity’s income tax disclosures around its effective rate reconciliation, income taxes paid, disaggregation of income before income taxes and income tax expense. The Company will adopt this standard in its Form 10-K for the fiscal year ending December 31, 2025. The adoption of this standard will result in expanded disclosures in the Notes to Consolidated Financial Statements.
In November 2024, the FASB issued ASU 2024-03,* Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses*, which aims to provide more detailed information about the types of expenses in commonly presented expense captions. The Company will adopt this standard in its Form 10-K for the fiscal year ending December 31, 2027. The Company is evaluating the impact of adoption on its Consolidated Financial Statements.
2. REVENUE RECOGNITION
Revenue from Product Sales
The Company generates revenue primarily from product sales, which include assembled and tested integrated circuits (“ICs”), power modules as well as dies in wafer form. The remaining revenue, which primarily consists of royalty revenue from licensing arrangements and revenue from wafer testing services performed for third parties, was not significant in any of the periods presented. See Note 7 to our unaudited condensed consolidated financial statements for the disaggregation of the Company’s revenue by geographic region.
The Company sells its products to end customers primarily through third-party distributors and value-added resellers. For the three months ended September 30, 2025 and 2024,85% and 88%, respectively, of the Company’s total sales were made through distribution arrangements. For the nine months ended September 30, 2025 and 2024,84% and 89%, respectively, of the Company’s total sales were made through distribution arrangements. These distribution arrangements contain enforceable rights and obligations specific to those distributors and not the end customers. Purchase orders, which are generally governed by sales agreements or the Company’s standard terms of sale, set the final terms for unit price, quantity, shipping and payment agreed between the Company and the customer. The Company considers purchase orders to be the contracts with customers. The unit price stated on purchase orders is considered to be the observable, stand-alone selling price for customer sales arrangements.
The Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company excludes taxes assessed by government authorities, such as sales taxes, from revenue.
Product sales consist of a single performance obligation that the Company satisfies at a point in time. The Company recognizes product revenue from distributors and direct end customers when the following events have occurred: (a) the Company has transferred physical possession of the products, (b) the Company has a present right to payment, (c) the customer has legal title to the products, and (d) the customer bears significant risks and rewards of ownership of the products. In accordance with the shipping terms specified in the contracts, these criteria are generally met when the products are shipped from the Company’s facilities (such as the “Ex Works” shipping term) or delivered to the customers’ locations (such as the “Delivered Duty Paid” shipping term).
Under certain consignment agreements, the Company recognizes revenue when customers consume products from the consigned inventory locations, at which time control transfers to the customers and the Company issues invoices.
Variable Consideration
The Company accounts for price adjustments and stock rotation rights as variable consideration that reduces the transaction price and recognizes that reduction in the same period the associated revenue is recognized. Certain U.S.-based distributors have price adjustment rights when they sell the Company’s products to their customers at a price that is lower than the distribution price invoiced by the Company. When the Company receives claims from the distributors that products have been sold to the end customers at the lower prices, the Company issues the distributors credit memos for the price adjustments. The Company estimates the price adjustments using the expected value method based on an analysis of historical claims, at both the distributor and product level, as well as an assessment of any known trends of product sales mix. Other U.S. distributors and non-U.S. distributors do not have price adjustment rights. The Company records a credit against accounts receivable for the estimated price adjustments with a corresponding reduction to revenue.
Certain distributors have limited stock rotation rights that permit the return of a small percentage of the previous six months’ purchases in accordance with the contract terms. The Company estimates the stock rotation returns using the expected value method based on an analysis of historical returns, and the current level of inventory in the distribution channel. The Company records a liability for the stock rotation reserve, with a corresponding reduction to revenue. In addition, the Company recognizes an asset for product returns which represents the right to recover products from the customers related to stock rotations, with a corresponding reduction to cost of revenue.
Contract Balances
Accounts Receivable:
The Company records a receivable when it has an unconditional right to receive consideration after the performance obligations are satisfied. The Company’s accounts receivable are short-term, with standard payment terms generally ranging from 30 to 90 days. The Company does not require its customers to provide collateral to support accounts receivable. The Company assesses collectability by reviewing accounts receivable on a customer-by-customer basis. To manage credit risk, management performs ongoing credit evaluations of the customers’ financial condition, monitors payment performance, and assesses current economic conditions, as well as reasonable and supportable forecasts of future economic conditions, that may affect collectability of the outstanding receivables. For certain customers, the Company requires standby letters of credit or advance payments prior to shipments of goods. The Company did not recognize any write-offs of accounts receivable or record any allowance for credit losses for the periods presented.
Contract Liabilities:
For customers without credit terms, the Company requires cash paymentstwo weeks before the products are scheduled to be shipped to the customers. The Company records these payments received in advance of performance as customer prepayments within other accrued liabilities. As of September 30, 2025 and December 31, 2024, customer prepayments totaled $9.4 million and $6.9 million, respectively. All of the customer prepayment balance as of December 31, 2024 has been fulfilled by the Company during the nine months ended September 30, 2025.
Practical Expedients
The Company has elected the practical expedient to expense sales commissions as incurred because the amortization period would have been one year or less.
The Company’s standard payment terms generally require customers to pay 30 to 90 days after the Company satisfies the performance obligations. For this reason, the Company has elected not to determine whether contracts with customers contain significant financing components.
The Company’s unsatisfied performance obligations primarily include products held in consignment arrangements and customer purchase orders for products that the Company has not yet shipped. Because the Company expects to fulfill these performance obligations within one year, the Company has elected not to disclose the amount of these remaining performance obligations.
3. STOCK-BASED COMPENSATION
2014 Equity Incentive Plan
In April 2013, the Board of Directors adopted the Company’s 2014 Equity Incentive Plan (the “2014 Plan”), which the Company’s stockholders approved in June 2013. In October 2014, the Board of Directors approved certain amendments to the 2014 Plan. The amended 2014 Plan became effective on November 13, 2014 and provided for the issuance of up to 5.5 million shares. In April 2020, the Board of Directors further amended and restated the amended 2014 Plan (the “Amended and Restated 2014 Plan”), which the Company’s stockholders approved in June 2020. The Amended and Restated 2014 Plan became effective on June 11, 2020 and provides for the issuance of up to 10.5 million shares. The Amended and Restated 2014 Plan will cease being available for new awards on June 11, 2030. As of September 30, 2025,3.6 million shares remained available for future issuance under the Amended and Restated 2014 Plan.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Cost of revenue | $1,916 | $1,576 | $5,502 | $4,585 |
| Research and development (“R&D”) | 12,578 | 11,331 | 36,725 | 33,460 |
| Selling, general and administrative (“SG&A”) | 46,183 | 38,491 | 131,354 | 111,585 |
| Total stock-based compensation expense | $60,677 | $51,398 | $173,581 | $149,630 |
| Tax benefit related to stock-based compensation (1) | $756 | $766 | $1,919 | $2,272 |
| (1) | Amount reflects the tax benefit related to stock-based compensation recorded for equity awards that are expected to generate tax deductions when they vest in future periods. Equity awards granted to the Company’s executive officers are subject to the tax deduction limitations set by Section 162(m) of the Internal Revenue Code. |
Restricted Stock Units (“RSUs”)
The Company’s RSUs include time-based RSUs, RSUs with performance conditions (“PSUs”), RSUs with market conditions (“MSUs”), and RSUs with both market and performance conditions (“MPSUs”). Vesting of awards with performance conditions or market conditions is subject to the achievement of pre-determined performance or market goals and the approval of such achievement by the Compensation Committee of the Board of Directors (the “Compensation Committee”). All awards include service conditions which require continued employment with or service to the Company.
A summary of RSU activity is presented in the table below (in thousands, except per-share amounts):
| Time-Based RSUs · PSUs and MPSUs · MSUs · Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted- · Weighted- · Weighted- · Weighted- | ||||||||||
| Average · Average · Average · Average | ||||||||||
| Grant Date · Grant Date · Grant Date · Grant Date | ||||||||||
| Number of · Fair Value · Number of · Fair Value · Number of · Fair Value · Number of · Fair Value | ||||||||||
| Shares · Per Share · Shares · Per Share · Shares · Per Share · Shares · Per Share | ||||||||||
| Outstanding at January 1, 2025 | 85 | $516.12 | 681 | $524.08 | 938 | $203.32 | 1,704 | $347.01 | ||
| Granted | 38 | $650.32 | 274 | (1) | $564.69 | - | $ | - | 312 | $574.95 |
| Vested | (33) | $477.06 | (40) | $400.90 | - | $ | - | (73) | $435.39 | |
| Forfeited | (5) | $565.80 | (4) | $526.65 | (11) | $297.45 | (20) | $413.13 | ||
| Outstanding at September 30, 2025 | 85 | $589.21 | 911 | $541.13 | 927 | $202.25 | 1,923 | $379.76 | ||
| (1) | Amount reflects the number of awards that may ultimately be earned based on management’s probability assessment of the achievement of performance conditions at each reporting period. |
The intrinsic value related to vested RSUs was $49.6 million and $494.4 million for the nine months ended September 30, 2025 and 2024, respectively. The decrease in the intrinsic value was primarily due to the timing of vested RSUs. As of September 30, 2025, the total intrinsic value of all outstanding RSUs was $1.7 billion, based on the closing stock price of $920.64. As of September 30, 2025, unamortized compensation expense related to all outstanding RSUs was $260.7 million with a weighted-average remaining recognition period of approximatelytwo years.
Time-Based RSUs:
For the nine months ended September 30, 2025, the Compensation Committee granted 38,000 RSUs with service conditions to non-executive employees and non-employee directors. The RSUs generally vest over four years for employees andone year for directors, subject to continued service with the Company.
2025 PSUs:
In February 2025, the Compensation Committee granted 50,000 PSUs to the executive officers, which represent the target number of shares that can be earned based on the degree of achievement of two sets of independent performance goals (“2025 Executive PSUs”). For the first goal, the executive officers can earn up to 300% of the target number of the 2025 Executive PSUs based on the achievement of the Company’s three-year (2025 through 2027) average revenue growth rate in excess of the analog industry’s three-year average revenue growth rate as published by the Semiconductor Industry Association (the “SIA”). For the second goal, the executive officers can earn up to 200% of the target number of the 2025 Executive PSUs based on the achievement of the Company’s three-year (2025 through 2027) total stockholder return percentile ranking relative to the constituent entities in the Philadelphia Semiconductor Sector Index (the “PHLX Index”). For both goals, a percentage of the 2025 Executive PSUs will fully vest on December 31, 2027, depending on the degree to which the pre-determined goals are met during the performance period. Assuming the achievement of the highest level of the performance goals, the total stock-based compensation cost for the 2025 Executive PSUs will be $138.5 million.
In February 2025, the Compensation Committee granted 11,000 PSUs to certain non-executive employees, which represent the target number of shares that can be earned based on the degree of achievement of the Company’s 2026 revenue goals for certain regions or product line divisions, or based on the degree of achievement of the Company’s two-year (2025 and 2026) average revenue growth rate compared against the analog industry’s two-year average revenue growth rate as published by the SIA (“2025 Non-Executive PSUs”). The maximum number of shares that an employee can earn is either 200% or 300% of the target number of the 2025 Non-Executive PSUs, depending on the job classification of the employee.50% of the 2025 Non-Executive PSUs will vest in the first quarter of 2027 depending on the degree to which the pre-determined goals are met during the performance period. The remaining 2025 Non-Executive PSUs will vest over the following two years on a quarterly or annual basis. Assuming the achievement of the highest level of performance goals, the total stock-based compensation cost for the 2025 Non-Executive PSUs will be $16.5 million.
The 2025 Executive PSUs and the 2025 Non-Executive PSUs contain a purchase price feature, which requires the employees to pay the Company $30 per share upon vesting of the shares. The $30 purchase price requirement is deemed satisfied and waived if the Company’s stock price on the last trading day of the performance period is $30 higher than the grant date stock price of $656.29. The Company determined the grant date fair value of the 2025 Executive PSUs and the 2025 Non-Executive PSUs using a Monte Carlo simulation model with the following assumptions: stock price of $656.29, simulation term ofthree years, expected volatility of 54.42%, risk-free interest rate of 4.20%, and expected dividend yield of 0.95%. The Monte Carlo simulation model for the 2025 Executive PSUs further utilized correlation coefficients of peer companies of 0.46 to 0.76. The correlation coefficients were based on peer companies in the PHLX Index as an aggregate benchmark for determining the market-based total stockholder return component. There is no illiquidity discount because the awards do not contain any post-vesting sales restrictions.
4. BALANCE SHEET COMPONENTS
Inventories
Inventories consist of the following (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Raw materials | $77,254 | $91,851 |
| Work in process | 210,471 | 169,982 |
| Finished goods | 217,955 | 157,778 |
| Total | $505,680 | $419,611 |
Other Current Assets
Other current assets consist of the following (in thousands):
| September 30, · December 31, | |||
|---|---|---|---|
| 2025 · 2024 | |||
| Prepaid wafer expenses (1) | $60,000 | $ | - |
| Other receivables (1) | - | 60,000 | |
| Other | 36,021 | 49,978 | |
| Total | $96,021 | $109,978 | |
| (1) | Prepaid wafer expenses and other receivables relate to a deposit made to a supplier under a long-term wafer supply agreement. See Note 8 to our unaudited condensed consolidated financial statements for details about the supply agreement. |
Other Long-Term Assets
Other long-term assets consist of the following (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan assets | $101,905 | $92,586 |
| Prepaid wafer purchases (1) | - | 60,000 |
| Other | 59,150 | 41,791 |
| Total | $161,055 | $194,377 |
| (1) | Prepaid wafer purchases relate to a deposit made to a supplier under a long-term wafer supply agreement. See Note 8 to our unaudited condensed consolidated financial statements for details about the supply agreement. |
Other Accrued Liabilities
Other accrued liabilities consist of the following (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Dividends and dividend equivalents | $79,935 | $60,622 |
| Income tax payable (1) | 51,350 | 10,534 |
| Stock rotation and sales returns | 31,854 | 20,799 |
| Other | 38,374 | 36,168 |
| Total | $201,513 | $128,123 |
| (1) | The increase in income tax payable during the nine months ended September 30, 2025 was a result of the timing of payments of estimated taxes both domestically and internationally. |
Other Long-Term Liabilities
Other long-term liabilities consist of the following (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan liabilities | $98,926 | $93,653 |
| Operating lease liabilities | 15,076 | 12,974 |
| Dividend equivalents | 3,378 | 4,943 |
| Total | $117,380 | $111,570 |
5. LEASES
The Company has operating leases primarily for administrative, sales and marketing offices, manufacturing operations and R&D facilities, and employee housing units. These leases have remaining lease terms from less thanone year to 19 years. Some of these leases include options to renew the lease term for up tofive years or on a month-to-month basis. The Company does not have finance lease arrangements.
The following table summarizes the balances of operating lease right-of-use (“ROU”) assets and liabilities (in thousands):
| September 30, · December 31, | |||
|---|---|---|---|
| Financial Statement Line Item | 2025 | 2024 | |
| Operating lease ROU assets | Other long-term assets | $19,737 | $16,915 |
| Operating lease liabilities | Other accrued liabilities | $3,778 | $2,819 |
| Other long-term liabilities | $15,076 | $12,974 | |
The following tables summarize certain information related to the leases (in thousands, except percentages and years):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Lease costs: | ||||
| Operating lease costs | $1,350 | $948 | $3,742 | $2,859 |
| Other | 864 | 822 | 2,458 | 2,020 |
| Total lease costs | $2,214 | $1,770 | $6,200 | $4,879 |
| Three Months Ended September 30, · Nine Months Ended September 30, | |||||
|---|---|---|---|---|---|
| 2025 · 2024 · 2025 · 2024 | |||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||
| Operating cash flows for operating leases | $1,273 | $1,704 | $3,434 | $3,404 | |
| ROU assets obtained in exchange for new operating lease liabilities | $ | - | $2,339 | $5,206 | $11,610 |
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Weighted-average remaining lease term (in years) | 9.7 | 11.5 |
| Weighted-average discount rate | 5.5% | 5.5% |
As of September 30, 2025, the maturities of the lease liabilities were as follows (in thousands):
| 2025 (remaining three months) | $1,300 |
| 2026 | 4,441 |
| 2027 | 3,937 |
| 2028 | 2,743 |
| 2029 | 1,954 |
| Thereafter | 11,471 |
| Total remaining lease payments | 25,846 |
| Less: imputed interest | (6,992) |
| Total lease liabilities | $18,854 |
As of September 30, 2025*,*the Company’s operating leases that had not yet commenced were not material.
6. NET INCOME PER SHARE
Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding for the period. Diluted net income per share reflects the potential dilution from contingently issuable shares and calculated using the treasury stock method. Contingently issuable shares, including all types of equity awards, are considered outstanding shares of common stock and included in basic net income per share as of the date that all necessary conditions to earn the awards have been satisfied. Prior to the end of the contingency period, the number of contingently issuable shares included in diluted net income per share is based on the number of shares, if any, that would be issuable under the terms of the arrangement at the end of the reporting period.
The following table sets forth the computation of basic and diluted net income per share (in thousands, except per-share amounts):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Numerator: | ||||
| Net income | $178,274 | $144,430 | $445,791 | $337,337 |
| Denominator: | ||||
| Weighted-average outstanding shares—basic | 47,898 | 48,757 | 47,879 | 48,692 |
| Effect of dilutive securities | 144 | 207 | 143 | 253 |
| Weighted-average outstanding shares—diluted | 48,042 | 48,964 | 48,022 | 48,945 |
| Net income per share: | ||||
| Basic | $3.72 | $2.96 | $9.31 | $6.93 |
| Diluted | $3.71 | $2.95 | $9.28 | $6.89 |
Anti-dilutive common stock equivalents were not material for the periods presented.
7. SEGMENT, SIGNIFICANT CUSTOMERS AND GEOGRAPHIC INFORMATION
The Company operates inone reportable segment that includes the design, development, marketing and sale of high-performance, semiconductor-based power electronics solutions for the storage and computing, automotive, enterprise data, communications, consumer, and industrial end markets. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Specifically, the CODM uses net income that is reported on the Condensed Consolidated Statements of Operations and cash provided by operating activities reported in the Condensed Consolidated Statements of Cash Flows to decide whether and how much to reinvest profits into core business operations or to return to stockholders in the form of stock repurchases and dividends.
All significant segment expenses have been captured on the face of the Condensed Consolidated Statements of Operations.
The Company sells its products to end customers primarily through third-party distributors and value-added resellers. The following table summarizes those customers with sales equal to 10% or more of the Company’s total revenue for the periods presented:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| Customer | 2025 | 2024 | 2025 | 2024 |
| Distributor A | 26% | 24% | 25% | 33% |
| Distributor B | 18% | 25% | 18% | 19% |
| Distributor C | * | * | 10% | * |
*Represents less than 10%.
The Company’s agreements with these third-party distributors were made in the ordinary course of business and may be terminated with or without cause by either party with advance notice. Although the Company may experience a short-term disruption in the distribution of its products and a short-term decline in revenue if its agreement with any of the distributors were terminated, the Company believes that such termination would not have a material adverse effect on its financial statements because it would be able to engage alternative distributors, resellers and other distribution channels to deliver its products to end customers within a short period following any termination of the agreement with a distributor.
The following table summarizes those customers with accounts receivable equal to 10% or more of the Company’s total net accounts receivable:
| September 30, | December 31, | |
|---|---|---|
| Customer | 2025 | 2024 |
| Distributor A | 31% | 28% |
| Distributor B | 17% | 29% |
The Company derives a majority of its revenue from sales to customers located outside North America, with geographic revenue based on the customers’ ship-to locations. The following is a summary of revenue by geographic region (in thousands) for the periods presented:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| Country or Region | 2025 | 2024 | 2025 | 2024 |
| China | $393,837 | $310,472 | $1,155,508 | $856,026 |
| Taiwan | 155,978 | 179,747 | 377,289 | 407,593 |
| South Korea | 62,882 | 51,815 | 190,747 | 126,865 |
| Southeast Asia | 39,023 | 22,772 | 106,596 | 47,363 |
| Europe | 33,577 | 25,145 | 85,066 | 61,992 |
| U.S. | 29,937 | 13,797 | 63,313 | 42,544 |
| Japan | 21,779 | 16,286 | 60,416 | 42,786 |
| Other | 163 | 85 | 369 | 266 |
| Total | $737,176 | $620,119 | $2,039,304 | $1,585,435 |
The following is a summary of long-lived assets by geographic region (in thousands):
| September 30, | December 31, | |
|---|---|---|
| Country | 2025 | 2024 |
| China | $308,174 | $237,649 |
| U.S. | 170,934 | 171,514 |
| Taiwan | 58,764 | 42,388 |
| Other | 59,439 | 43,394 |
| Total | $597,311 | $494,945 |
8. COMMITMENTS AND CONTINGENCIES
Product Warranties and Rework
The Company generally provides either aone- ortwo-year warranty against defects in materials and workmanship and will repair products, provide replacements at no charge to customers or issue a refund. As they are considered assurance-type warranties, the Company does not account for them as separate performance obligations. Historically, the Company’s warranty obligations have not been material. The Company may also incur rework costs associated with product-related claims. The Company accrues for warranty and rework costs upon evaluation of customer specific claims.
The changes in warranty reserves were as follows (in thousands) for the periods presented:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Balance at beginning of period | $3,045 | $14,702 | $5,401 | $16,906 |
| Warranties issued | 2,665 | 570 | 3,230 | 2,895 |
| Repairs, replacement and refund | (145) | (849) | (1,633) | (4,979) |
| Changes in liability for pre-existing warranties | 760 | (79) | (673) | (478) |
| Balance at end of period | $6,325 | $14,344 | $6,325 | $14,344 |
Purchase Commitments
The Company has outstanding purchase obligations with its suppliers and other parties for purchases of goods or services. The purchase obligations primarily consist of wafer and other inventory purchases, assembly and other manufacturing services, construction of manufacturing and R&D facilities, purchases of production and other equipment, and license arrangements.
In May 2022, the Company entered into a long-term supply agreement in order to secure manufacturing production capacity for silicon wafers over a four-year period. As of September 30, 2025, the Company had remaining prepayments under this agreement of $60.0 million reported in other current assets on the Condensed Consolidated Balance Sheets.
Total estimated future unconditional purchase commitments to all suppliers and other parties, net of the $60.0 million prepayment, as of September 30, 2025 were as follows (in thousands):
| 2025 (remaining three months) | $117,079 |
| 2026 | 349,330 |
| 2027 | 31,936 |
| 2028 | 486 |
| 2029 | 486 |
| Total | $499,317 |
Litigation
The Company is a party to actions and proceedings in the ordinary course of business, including challenges to the enforceability or validity of its intellectual property, claims that the Company’s products infringe on the intellectual property rights of others, and employment matters. The Company is also subject to litigation initiated by its stockholders. These proceedings often involve complex questions of fact and law and may require the expenditure of significant funds and the diversion of other resources to prosecute and defend. The Company defends itself vigorously against any such claims. Based on current information, the Company does not believe that a material loss from known matters is probable as of September 30, 2025.
9. CASH, CASH EQUIVALENTS, INVESTMENTS AND RESTRICTED CASH
The following is a summary of the Company’s cash, cash equivalents and debt investments (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Cash | $580,992 | $679,949 |
| Money market funds | 500,259 | 11,867 |
| Certificates of deposit | 154,489 | 164,418 |
| U.S. treasuries and government agency bonds | 33,249 | - |
| Auction-rate securities backed by student-loan notes | 74 | 148 |
| Corporate debt securities | - | 6,712 |
| Total | $1,269,063 | $863,094 |
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Reported as: | ||
| Cash and cash equivalents | $1,081,251 | $691,816 |
| Investment within short-term investments | 187,738 | 171,130 |
| Investment within other long-term assets | 74 | 148 |
| Total | $1,269,063 | $863,094 |
The following table summarizes the contractual maturities of the short-term and long-term available-for-sale investments as of September 30, 2025 (in thousands):
| Amortized Cost | Fair Value | |
|---|---|---|
| Due in less than 1 year | $89,419 | $89,427 |
| Due in 1 - 5 years | 98,311 | 98,311 |
| Due in greater than 5 years | 75 | 74 |
| Total | $187,805 | $187,812 |
Gross realized gains and losses recognized on the sales of available-for-sale investments were not material for the periods presented.
The following tables summarize the unrealized gain and loss positions related to the available-for-sale investments (in thousands):
| Amortized Cost · Unrealized Gains · Unrealized Losses · Fair Value | ||||||
|---|---|---|---|---|---|---|
| Money market funds | $500,259 | $ | - | $ | - | $500,259 |
| Certificates of deposit | 154,489 | - | - | 154,489 | ||
| U.S. treasuries and government agency bonds | 33,241 | 8 | - | 33,249 | ||
| Auction-rate securities backed by student-loan notes | 75 | - | (1) | 74 | ||
| Total | $688,064 | $8 | $(1) | $688,071 | ||
| Amortized Cost · Unrealized Losses · Fair Value | ||||
|---|---|---|---|---|
| Money market funds | $11,867 | $ | - | $11,867 |
| Certificates of deposit | 164,418 | - | 164,418 | |
| Corporate debt securities | 6,779 | (67) | 6,712 | |
| Auction-rate securities backed by student-loan notes | 150 | (2) | 148 | |
| Total | $183,214 | $(69) | $183,145 | |
The following tables present information about the available-for-sale investments that had been in a continuous unrealized loss position for greater than 12 months (in thousands):
| Greater than 12 Months | ||
|---|---|---|
| Fair Value | Unrealized Losses | |
| Auction-rate securities backed by student-loan notes | $74 | $(1) |
| Total | $74 | $(1) |
| Greater than 12 Months | ||
|---|---|---|
| Fair Value | Unrealized Losses | |
| Corporate debt securities | $6,712 | $(67) |
| Auction-rate securities backed by student-loan notes | 148 | (2) |
| Total | $6,860 | $(69) |
An impairment exists when the fair value of an investment is less than its amortized cost basis. As of September 30, 2025 and December 31, 2024, the Company did not consider the impairment of its investments to be a result of credit losses. The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. When evaluating a debt security for impairment, management reviews factors such as the Company’s intent to sell, or whether it will more likely than not be required to sell, the security before recovery of its amortized cost basis, the extent to which the fair value of the security is less than its cost, the financial condition of the issuer and the credit quality of the investment.
Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the amounts reported on the Condensed Consolidated Statements of Cash Flows (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Cash and cash equivalents | $1,081,251 | $691,816 |
| Restricted cash included in other long-term assets | 142 | 125 |
| Total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Statements of Cash Flows | $1,081,393 | $691,941 |
10. FAIR VALUE MEASUREMENTS
Fair Value Hierarchy
The Company has estimated the fair value of its financial assets by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
| ● | Level 1—includes instruments with quoted prices in active markets for identical assets. |
|---|---|
| ● | Level 2—includes instruments for which the valuations are based upon quoted market prices in active markets involving similar assets or inputs other than quoted prices that are observable for the assets. The market inputs used to value these instruments generally consist of market yields, recently executed transactions, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Pricing sources may include industry standard data providers, security master files from large financial institutions, and other third-party sources used to determine a daily market value. |
| ● | Level 3—includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. |
Financial Assets Measured at Fair Value on a Recurring Basis
The following tables detail the fair value of the Company’s financial assets measured on a recurring basis (in thousands):
| Total · Level 1 · Level 2 · Level 3 | ||||||
|---|---|---|---|---|---|---|
| Money market funds | $500,259 | $500,259 | $ | - | $ | - |
| Certificates of deposit | 154,489 | - | 154,489 | - | ||
| U.S. treasuries and government agency bonds | 33,249 | - | 33,249 | - | ||
| Auction-rate securities backed by student-loan notes | 74 | - | - | 74 | ||
| Mutual funds and money market funds under deferred compensation plan | 70,994 | 70,994 | - | - | ||
| Total | $759,065 | $571,253 | $187,738 | $74 | ||
| Total · Level 1 · Level 2 · Level 3 | ||||||
|---|---|---|---|---|---|---|
| Money market funds | $11,867 | $11,867 | $ | - | $ | - |
| Certificates of deposit | 164,418 | - | 164,418 | - | ||
| Corporate debt securities | 6,712 | - | 6,712 | - | ||
| Auction-rate securities backed by student-loan notes | 148 | - | - | 148 | ||
| Mutual funds and money market funds under deferred compensation plan | 65,337 | 65,337 | - | - | ||
| Total | $248,482 | $77,204 | $171,130 | $148 | ||
Redemptions and changes in the fair value of the auction-rate securities classified as Level 3 assets were not material for the periods presented.
11. DEFERRED COMPENSATION PLAN
The following table summarizes the deferred compensation plan balances on the Condensed Consolidated Balance Sheets (in thousands):
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan asset components: | ||
| Cash surrender value of corporate-owned life insurance policies | $30,911 | $27,249 |
| Fair value of mutual funds and money market funds | 70,994 | 65,337 |
| Total | $101,905 | $92,586 |
| Deferred compensation plan assets reported in: | ||
| Other long-term assets | $101,905 | $92,586 |
| Deferred compensation plan liabilities reported in: | ||
| Accrued compensation and related benefits | $3,656 | $2,323 |
| Other long-term liabilities | 98,926 | 93,653 |
| Total | $102,582 | $95,976 |
12. OTHER INCOME, NET
The components of other income, net, were as follows (in thousands) for the periods presented:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Interest income | $8,338 | $6,805 | $20,078 | $20,349 |
| Amortization of discount on available-for-sale securities | 1,009 | 6,644 | 3,894 | 16,684 |
| Gain on deferred compensation plan investments | 3,793 | 3,894 | 8,023 | 9,180 |
| Charitable commitments | (3,194) | (6,400) | (4,094) | (18,550) |
| Other | 446 | (665) | (158) | (333) |
| Total | $10,392 | $10,278 | $27,743 | $27,330 |
13. INCOME TAXES
The income tax provision or benefit for interim periods is generally determined using an estimate of the Company’s annual effective tax rate and adjusted for discrete items, if any, in the relevant period. Each quarter the estimate of the annual effective tax rate is updated, and if the Company’s estimated tax rate changes, a cumulative adjustment is made.
The budget reconciliation bill H.R.1 (“H.R.1 Act”) signed into law on July 4, 2025 makes permanent certain expiring provisions of the 2017 Tax Cuts and Jobs Act and makes modifications to the existing tax framework. The modifications that primarily impact the Company for the current year are the immediate expensing of domestic R&D and 100% bonus depreciation. The Company’s tax provision for the three and nine months ended September 30, 2025 includes the estimated impact of the H.R.1 Act.
The income tax expense for the three months ended September 30, 2025 was $27.3 million, or 13.3% of pre-tax income. The income tax expense for the nine months ended September 30, 2025 was $110.7 million, or 19.9% of pre-tax income. The effective tax rates were lower than the federal statutory rate of 21% primarily due to the effect of U.S. federal tax law changes enacted during the quarter, income generated by the Company’s subsidiaries in lower tax jurisdictions, foreign tax credits, and U.S. R&D credits. The lower effective tax rates relative to the federal statutory rate were partially offset by the U.S. impact of foreign earnings and non-deductible stock-based compensation.
The income tax expense for the three months ended September 30, 2024 was $29.9 million, or 17.1% of pre-tax income. The income tax expense for the nine months ended September 30, 2024 was $66.0 million, or 16.4% of pre-tax income. The effective tax rates were lower than the federal statutory rate of 21% primarily due to lower statutory tax rates at certain foreign subsidiaries of the Company, and excess tax benefits from stock-based compensation. The lower effective tax rates relative to the federal statutory rate were partially offset by the U.S. impact of foreign earnings.
In January 2025, the Organization for Economic Co-operation and Development (“OECD”) released new Administrative Guidance on the application of the Global Anti-Base Erosion (“GLoBE”) Model Rules. The Company will continue to evaluate the impact of this release and of other future guidance on the Company’s future global tax provision.
In December 2023, the Bermuda Corporate Income Tax Act of 2023 (the “Bermuda CIT Act”) was enacted and signed into law. The Bermuda CIT Act includes a 15% corporate income tax applicable to Bermuda businesses that are multinational enterprises with annual revenue of €750M or more beginning in 2025. As the Company did not realize material taxable income in Bermuda in the three and nine months ended September 30, 2025, no material changes to income tax expense related to the Bermuda CIT Act have been recorded as of September 30, 2025.
14. ACCUMULATED OTHER COMPREHENSIVE LOSS
The following table summarizes the changes in accumulated other comprehensive loss (in thousands):
| Unrealized | |||
|---|---|---|---|
| Losses on · Foreign Currency | |||
| Available-for-Sale · Translation | |||
| Securities | Adjustments | Total | |
| Balance as of January 1, 2025 | $(790) | $(47,721) | $(48,511) |
| Other comprehensive income before reclassifications | 43 | 5,139 | 5,182 |
| Amounts reclassified from accumulated other comprehensive income | 5 | - | 5 |
| Net current period other comprehensive income | 48 | 5,139 | 5,187 |
| Balance as of March 31, 2025 | (742) | (42,582) | (43,324) |
| Other comprehensive income (loss) before reclassifications | (1) | 19,634 | 19,633 |
| Net current period other comprehensive income (loss) | (1) | 19,634 | 19,633 |
| Balance as of June 30, 2025 | (743) | (22,948) | (23,691) |
| Other comprehensive income before reclassifications | 86 | 919 | 1,005 |
| Tax effect | (17) | - | (17) |
| Net current period other comprehensive income | 69 | 919 | 988 |
| Balance as of September 30, 2025 | $(674) | $(22,029) | $(22,703) |
The amount reclassified from accumulated other comprehensive income for the period presented was recorded in other income, net, on the Condensed Consolidated Statements of Operations.
15. STOCKHOLDERS’ EQUITY
Cash Dividend Program
The Company has a dividend program approved by its Board of Directors, pursuant to which the Company intends to pay quarterly cash dividends on its common stock. The Board of Directors declared the following cash dividends (in thousands, except per-share amounts) for the periods presented:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Dividend declared per share | $1.56 | $1.25 | $4.68 | $3.75 |
| Total amount | $74,731 | $60,974 | $224,130 | $182,680 |
As of September 30, 2025 and December 31, 2024, accrued cash dividends totaled $74.7 million and $59.8 million, respectively.
The declaration of any future cash dividends is at the discretion of the Board of Directors and will depend on, among other things, the Company’s financial condition, results of operations, capital requirements, business conditions, and other factors that the Board of Directors may deem relevant, as well as a determination that cash dividends are in the best interests of the Company’s stockholders.
The Company anticipates that cash used for future dividend payments will come from its domestic cash, cash generated from ongoing U.S. operations, and cash repatriated from certain foreign subsidiaries. The Company also anticipates that earnings from other foreign subsidiaries will continue to be indefinitely reinvested.
Cash Dividend Equivalent Rights
The Company’s RSUs contain rights to receive cash dividend equivalents, which entitle employees who hold RSUs to the same dividend value per share as holders of common stock. The dividend equivalents are accumulated and paid to the employees after the underlying RSUs vest. Dividend equivalents accumulated on the underlying RSUs are forfeited if the underlying RSUs do not vest. As of September 30, 2025 and December 31, 2024*,* accrued dividend equivalents totaled $8.6 million and $5.8 million, respectively.
Stock Repurchase Programs
In October 2023, the Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to $640.0 million of its common stock, which was fully utilized as of December 31, 2024. In February 2025, the Board of Directors approved another stock repurchase program authorizing the Company to repurchase up to $500.0 million of its common stock through February 2028. Shares are retired upon repurchase. The Company repurchased 2,000 and 6,000 shares of its common stock for an aggregate purchase price of $2.1 million and $5.5 million during the three months ended September 30, 2025 and 2024, respectively. The Company repurchased 6,000 and 19,000 shares of its common stock for an aggregate purchase price of $4.7 million and $14.2 million during the nine months ended September 30, 2025 and 2024, respectively. As of September 30, 2025, $495.3 million remained available for future repurchases under the program.
Stock repurchased under the program may be made through open market repurchases, privately negotiated transactions, or other structures, in accordance with applicable state and federal securities laws, at times and in amounts as management deems appropriate. The timing and the number of any repurchased common stock will be determined by the Company’s management based on its evaluation of market conditions, legal requirements, share price, and other factors. The repurchase program does not obligate the Company to purchase any particular number of shares, and may be suspended, modified, or discontinued at any time without prior notice.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.